
Sign up to save your podcasts
Or


The bitcoin rally is showing no signs of slowing down. Standard Chartered's Geoff Kendrick and Ranger Equity Bear's David Tice debate the currency. Plus, Salesforce has issued a weaker-than-expected forecast but is initiating a $0.40 dividend. BNP Paribas Exane's Stefan Slowinski dives into the quarter. And, Ozempic and other GLP-1 drugs have disrupted the weight loss industry. Barclays' Emily Field explains.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.2
113113 ratings
The bitcoin rally is showing no signs of slowing down. Standard Chartered's Geoff Kendrick and Ranger Equity Bear's David Tice debate the currency. Plus, Salesforce has issued a weaker-than-expected forecast but is initiating a $0.40 dividend. BNP Paribas Exane's Stefan Slowinski dives into the quarter. And, Ozempic and other GLP-1 drugs have disrupted the weight loss industry. Barclays' Emily Field explains.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,089 Listeners

3,224 Listeners

1,363 Listeners

240 Listeners

149 Listeners

322 Listeners

296 Listeners

67 Listeners

154 Listeners

2,152 Listeners

597 Listeners

560 Listeners

20 Listeners

208 Listeners

416 Listeners

301 Listeners

808 Listeners

180 Listeners

62 Listeners

156 Listeners

34 Listeners

12 Listeners

23 Listeners

10 Listeners

16 Listeners